Comparative Analysis of the Placental Microbiome in Pregnancies with Late Fetal Growth Restriction versus Physiological Pregnancies.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Apr 2023
Historique:
received: 06 03 2023
revised: 03 04 2023
accepted: 06 04 2023
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

A comparative analysis of the placental microbiome in pregnancies with late fetal growth restriction (FGR) was performed with normal pregnancies to assess the impact of bacteria on placental development and function. The presence of microorganisms in the placenta, amniotic fluid, fetal membranes and umbilical cord blood throughout pregnancy disproves the theory of the "sterile uterus". FGR occurs when the fetus is unable to follow a biophysically determined growth path. Bacterial infections have been linked to maternal overproduction of pro-inflammatory cytokines, as well as various short- and long-term problems. Proteomics and bioinformatics studies of placental biomass allowed the development of new diagnostic options. In this study, the microbiome of normal and FGR placentas was analyzed by LC-ESI-MS/MS mass spectrometry, and the bacteria present in both placentas were identified by analysis of a set of bacterial proteins. Thirty-six pregnant Caucasian women participated in the study, including 18 women with normal pregnancy and eutrophic fetuses (EFW > 10th percentile) and 18 women with late FGR diagnosed after 32 weeks of gestation. Based on the analysis of the proteinogram, 166 bacterial proteins were detected in the material taken from the placentas in the study group. Of these, 21 proteins had an exponentially modified protein abundance index (emPAI) value of 0 and were not included in further analysis. Of the remaining 145 proteins, 52 were also present in the material from the control group. The remaining 93 proteins were present only in the material collected from the study group. Based on the proteinogram analysis, 732 bacterial proteins were detected in the material taken from the control group. Of these, 104 proteins had an emPAI value of 0 and were not included in further analysis. Of the remaining 628 proteins, 52 were also present in the material from the study group. The remaining 576 proteins were present only in the material taken from the control group. In both groups, we considered the result of ns prot ≥ 60 as the cut-off value for the agreement of the detected protein with its theoretical counterpart. Our study found significantly higher emPAI values of proteins representative of the following bacteria:

Identifiants

pubmed: 37108086
pii: ijms24086922
doi: 10.3390/ijms24086922
pmc: PMC10139004
pii:
doi:

Substances chimiques

Bacterial Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical University of Lublin
ID : DS 128

Références

Semin Reprod Med. 2014 Jan;32(1):35-42
pubmed: 24390919
Integr Med (Encinitas). 2014 Dec;13(6):17-22
pubmed: 26770121
Pregnancy Hypertens. 2021 Mar;23:211-219
pubmed: 33530034
Front Microbiol. 2016 May 31;7:744
pubmed: 27303369
BMC Pregnancy Childbirth. 2022 Apr 7;22(1):297
pubmed: 35392848
Biol Reprod. 2022 Aug 9;107(2):371-381
pubmed: 35412586
Science. 1989 Nov 24;246(4933):1034-8
pubmed: 2511628
Curr Opin Gastroenterol. 2015 Jan;31(1):69-75
pubmed: 25394236
Ultrasound Obstet Gynecol. 2007 Sep;30(3):303-11
pubmed: 17721870
J Reprod Immunol. 2022 Feb;149:103455
pubmed: 34883392
J Low Genit Tract Dis. 2022 Jan 1;26(1):73-78
pubmed: 34928256
Mol Cell Proteomics. 2005 Sep;4(9):1265-72
pubmed: 15958392
Medicine (Baltimore). 2020 Nov 13;99(46):e22722
pubmed: 33181648
Front Immunol. 2019 Oct 23;10:2494
pubmed: 31749800
BJOG. 2011 Apr;118(5):533-49
pubmed: 21251190
Crit Rev Microbiol. 2022 Sep;48(5):611-623
pubmed: 34788162
Pediatr Endocrinol Rev. 2009 Feb;6 Suppl 3:332-6
pubmed: 19404231
Mol Med Rep. 2022 Dec;26(6):
pubmed: 36263610
Helicobacter. 2017 Apr;22(2):
pubmed: 27786400
Arch Gynecol Obstet. 2017 May;295(5):1061-1077
pubmed: 28285426
Pathogens. 2020 Feb 22;9(2):
pubmed: 32098432
Microbiome. 2014 Oct 13;2:38
pubmed: 25332768
Ultrasound Obstet Gynecol. 2016 Sep;48(3):333-9
pubmed: 26909664
Clin Obstet Gynecol. 2006 Jun;49(2):228-35
pubmed: 16721103
Genome Med. 2022 Jan 11;14(1):4
pubmed: 35016706
Phytochemistry. 2007 Jun;68(12):1612-22
pubmed: 17512564
Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1:3-57
pubmed: 33740264
Gut. 2022 Dec;71(12):2451-2462
pubmed: 35387876
Reprod Sci. 2021 Mar;28(3):828-837
pubmed: 33107014
Circ Res. 2022 Sep 2;131(6):492-506
pubmed: 35950704
PLoS One. 2020 Aug 10;15(8):e0237232
pubmed: 32776951
Science. 2016 Mar 18;351(6279):1296-302
pubmed: 26989247
Gut. 2018 Sep;67(9):1716-1725
pubmed: 29934437
Am J Obstet Gynecol. 1985 Feb 1;151(3):333-7
pubmed: 3881966
BMC Pregnancy Childbirth. 2013 Feb 25;13:50
pubmed: 23442391
Early Hum Dev. 2014 Mar;90 Suppl 1:S42-4
pubmed: 24709457
Nat Med. 2016 Oct;22(10):1187-1191
pubmed: 27618652
Nat Commun. 2018 Oct 26;9(1):4462
pubmed: 30367045
J Clin Microbiol. 1994 Sep;32(9):2162-8
pubmed: 7814541
J Nat Prod. 2011 Sep 23;74(9):1990-5
pubmed: 21870828
Ultrasound Obstet Gynecol. 2007 Sep;30(3):287-96
pubmed: 17721916
Sci Rep. 2017 Jun 6;7(1):2860
pubmed: 28588199
Ann Appl Stat. 2010;4(4):1797-1823
pubmed: 21593992

Auteurs

Aleksandra Stupak (A)

Chair and Department of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, 20-059 Lublin, Poland.

Tomasz Gęca (T)

Chair and Department of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, 20-059 Lublin, Poland.

Anna Kwaśniewska (A)

Chair and Department of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, 20-059 Lublin, Poland.

Radosław Mlak (R)

Body Composition Research Laboratory, Department of Preclinical Science, Medical University of Lublin, 20-059 Lublin, Poland.

Paweł Piwowarczyk (P)

2nd Department of Anesthesiology and Intensive Care Unit, Medical University of Lublin, 20-059 Lublin, Poland.

Robert Nawrot (R)

Department of Molecular Virology, Institute of Experimental Biology, Adam Mickiewicz University in Poznan, 61-712 Poznań, Poland.

Anna Goździcka-Józefiak (A)

Department of Molecular Virology, Institute of Experimental Biology, Adam Mickiewicz University in Poznan, 61-712 Poznań, Poland.

Wojciech Kwaśniewski (W)

Department of Gynecologic Oncology and Gynecology, Medical University of Lublin, 20-059 Lublin, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH